Xixi Lin
269 Zhanghua Middle Road
Zhangzhou, 363000, China
Zhangzhou, 363000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum to Axon guidance cue SLIT2 regulates the murine skeletal stem cell niche through sympathetic innervation.
Journal: The Journal of clinical investigation
Published: January 16, 2026
Expression of Concern for Axon guidance cue SLIT2 regulates the murine skeletal stem cell niche through sympathetic innervation.
Journal: The Journal of clinical investigation
Published: December 15, 2025
Dual Outcomes of Schnurri-3 Inhibition in Psoriasis: Skeletal Rescue and Dermatological Aggravation.
Dual Outcomes of Schnurri-3 Inhibition in Psoriasis: Skeletal Rescue and Dermatological Aggravation.
Journal: International journal of rheumatic diseases
Published: June 11, 2025
Axon guidance cue SLIT2 regulates the murine skeletal stem cell niche through sympathetic innervation.
Journal: The Journal of clinical investigation
Published: March 05, 2025
Sinensetin serves as an AMPK activator to inhibit RANKL-induced osteoclastogenesis via osteoclast cytoskeleton reorganization.
Journal: Journal of translational medicine
Published: November 10, 2024
Skeletal stem cells in bone development, homeostasis, and disease.
Journal: Protein & cell
Published: December 18, 2023
Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 22, 2023
Innate lymphoid cells: New players in osteoimmunology.
Journal: European journal of immunology
Published: March 22, 2023
Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL-induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activation.
Journal: Free radical biology & medicine
Published: November 15, 2022
New perspective of skeletal stem cells.
Journal: Biomaterials translational
Published: November 09, 2022
Mogrol Attenuates Osteoclast Formation and Bone Resorption by Inhibiting the TRAF6/MAPK/NF-κB Signaling Pathway In vitro and Protects Against Osteoporosis in Postmenopausal Mice.
Journal: Frontiers in pharmacology
Published: October 28, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026